12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

BD ProbeTec HSV-1 and HSV-2 Qx Amplified DNA Assays regulatory update

Becton said its BD Diagnostics segment submitted a 510(k) application to FDA for its BD ProbeTec HSV-1 and HSV-2 Qx...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >